BeOne Medicines (BEIGF) Net Shares Issued and Repurchased (2015 - 2018)

BeOne Medicines (BEIGF) has reported Net Shares Issued and Repurchased for 4 consecutive years, with $457093.0 the latest figure, recorded in Q1 2018.

• On a quarterly basis, Net Shares Issued and Repurchased changed N/A year-over-year to $457093.0 in Q1 2018; TTM through Mar 2018 was $457093.0, a N/A change from a year earlier, with the FY2017 full-year figure at $62.1 million, up 59.52% from the prior year.
• Net Shares Issued and Repurchased was $457093.0 for Q1 2018 at BeOne Medicines, down from $62.1 million in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at $62.1 million in Q4 2017 and troughed at $457093.0 in Q1 2018.
• A 4-year average of $30.8 million and a median of $32.8 million in 2015 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased advanced 18.61% in 2016 and soared 59.52% in 2017, its largest moves.
• Over 4 years, Net Shares Issued and Repurchased stood at $32.8 million in 2015, then climbed by 18.61% to $38.9 million in 2016, then soared by 59.52% to $62.1 million in 2017, then sank by 99.26% to $457093.0 in 2018.
• The last three Net Shares Issued and Repurchased figures came in at $457093.0 (Q1 2018), $62.1 million (Q4 2017), and $38.9 million (Q4 2016), per Business Quant data.